Abstract
Background
The aim of this study was to gain an understanding of the transcriptomic changes that occur in a wild species when infected with Toxoplasma gondii. The masked palm civet, an artifically domesticated animal, was used as the model of a wild species. Transcriptome analysis was used to study alterations in gene expression in the domesticated masked palm civet after chronic infection with T. gondii.
Methods
Masked palm civets were infected with 105 T. gondii cysts and their brain tissue collected after 4 months of infection. RNA sequencing (RNA-Seq) was used to gain insight into the spectrum of genes that were differentially expressed due to infection. Quantitative reverse-transcription PCR (qRT-PCR) was also used to validate the level of expression of a set of differentially expressed genes (DEGs) obtained by sequencing.
Results
DEGs were screened from the sequencing results and analyzed. A total of 2808 DEGs were detected, of which 860 were upregulated and 1948 were downregulated. RNA-Seq results were confirmed by qRT-PCR. DEGs were mainly enriched in cellular process and metabolic process based on gene ontology enrichment analysis. Kyoto Encyclopedia of Genes and Genomes pathway analysis showed that transcriptional changes in the brain of infected masked palm civets evolved over the course of infection and that DEGs were mainly enriched in the signal transduction, immune system processes, transport and catabolic pathways. Finally, 10 essential driving genes were identified from the immune signaling pathway.
Conclusions
This study revealed novel host genes which may provide target genes for the development of new therapeutics and detection methods for T. gondii infection in wild animals.
Graphical Abstract
Supplementary Information
The online version contains supplementary material available at 10.1186/s13071-022-05378-5.
Keywords: Toxoplasma gondii, Masked palm civet, Gene expression, RNA-Seq
Background
Toxoplasma gondii is a protozoan parasite that infects exclusively eukaryotic cells. Toxoplasmosis is a major parasitic zoonosis caused by T. gondii [1]. The accidental consumption of food or water containing T. gondii oocysts is one of the routes by which organisms become infected with T. gondii. Toxoplasmosis can cause severe clinical symptoms and even death in infants, pregnant women and immunocompromised individuals [2, 3]. This parasite can infect all host tissues, but the central nervous system and muscles are the predilection sites [4]. Tachyzoites of T. gondii can invade almost all nucleated cells but have a particular affinity for nerve cells, resulting in T. gondii encephalitis [5]. Epidemiological surveys have shown that about 30% of the world's population is potentially infected with T. gondii [6]. Among the causes of death due to T. gondii, 90% are due to encephalitis, with a high proportion of secondary paralysis [7]. In addition, T. gondii is also one of the main factors affecting the health of patients with human immunodeficiency virus (HIV) [8]. Studies have shown that 65% of patients with HIV die from the re-activation of T. gondii infection in the first year after diagnosis [9]. Chronic T. gondii infection can also cause neurological diseases, such as schizophrenia and depression [10]. Felids can be both definitive and intermediate hosts of T. gondii. The ME49 strain (type II) of either moderate or low virulence to animal hosts is able to control the acute phase of the disease and able to establish chronic infections, and is the type most frequently associated with human and animal disease [11].
The masked palm civet, Paguma larvata (Mammalia: Carnivora: Viverridae), is a carnivore species widely distributed in the vast area south of the Yellow River in China [12]. Once served as food on plates in China, masked palm civets have become another transmission route of many zoonotic parasites, bacteria and viruses, such as T. gondii, Enterocytozoon bieneusi, Bartonella henselae, Salmonella enterica, Campylobacter spp. and Cryptosporidium spp. [13–16]. Studies on the changes in gene expression in wild animals following pathogen infection will provide critical information for analyzing host resistance strategies.
In recent years, various “omics” methods have been developed and used in studies to explore the mechanism by which T. gondii invades the brain [17–19]. Based on the results of these studies, it can be concluded that pathogenesis of the host nervous system in T. gondii infection is driven by complex molecular processes and pathway networks [20–22]. The purpose of this study was to investigate the pathological changes in the brain of the masked palm civet chronically infected with T. gondii. The secondary purpose was to investigate the genes found to be associated with infection, and the patterns of these genes in the brain tissue of animals infected with T. gondii using transcriptome analysis. Transcriptome analysis of the mechanism by which T. gondii enters the brain can reveal different aspects of the host's immune response, prevention of infection and control mechanisms of wild species chronically infected with this protozoan.
Methods
Experimental animals
Six 3- to 4-month-old masked palm civets were purchased from the Jiahe Special Breeding Station in Shaoguan (Guangdong, China). All masked palm civets were confirmed to be negative for T. gondii using the modified agglutination test. For 3 weeks before the experiment, the animals were fed on a commercial diet provided with potable water according to the daily energy requirements of experimental animals.
Sample collection
Toxoplasma gondii ME49 strain (genotype #2) was cultured in Kunming mice in the Parasitology Laboratory of South China Agricultural University (Guangdong, China). Brain cysts of T. gondii were examined microscopically and their number adjusted to 103 cysts/ml in phosphate-buffered saline (PBS). Six masked civets were average divided into two groups, control group and intected group. Animals in the experimental group were infected by intragastric inoculation with 105 cysts of T. gondii in 1 ml sterile PBS. Animals in the control group remained uninfected and received 1 ml of sterile PBS only. After 4 months of experimental infection, the aseptic brain tissue of the experimental and control animals collected. The collected tissue samples were washed in saltwater, rapidly frozen in liquid nitrogen and stored at − 80 °C until further treatment.
Detection of T. gondii
DNA was extracted from the samples of brain tissue from the masked civets using the TIANamp Genomic DNA Kit (TianGen, Beijing, China). In an earlier study, Ye et al. [23] obtained the primer sequences against the T. gondii B1 gene and the bradyzoite antigen-1 (BAG1). The B1 gene primers (forward: 5′-TCTTTAAAGCGTTCGTGTC-3′; reverse: 5′-GGAACTGCATCCGTTCATGAG-3′) and BAG1 gene primers (forward: 5′-AGTCGACAACGGAGCCATCGTTA-3′; reverse: 5′-CCTTGATCGTGACACGTAGAACG-3′) were amplified for the quantitative reverse-transcription PCR (qRT-PCR) assays.
RNA extraction and identification
TRIzol reagent was utilized to extract total RNA from brain tissue. Approximately 50 mg of the sample was ground to powder with an appropriate amount of liquid nitrogen, and then 1 ml of TRIzol reagent homogenate was added [24]. The purity of the RNA was determined using the Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). Degradation and contamination of RNA was examined on a 2.5% agarose gel using a Qubit®3.0 fluorometer (Thermo Fisher Scientific). The integrity and total RNA amount were accurately detected on a Agilent 2100 bioanalyzer (Agilent Technologies Inc., Santa Clara, CA, USA).
Library preparation for transcriptome sequencing
RNA sample preparations utilized RNA as input material. Briefly, messenger RNA (mRNA) was purified from total extracted RNA using poly-oligo-attached magnetic beads, and then the mRNA was fragmented using divalent cations under elevated temperature, in First Strand Synthesis Reaction Buffer (5×) (Thermo Fisher Scientific). The first-strand cDNA was synthesized using random hexamer primer and the M-MuLV Reverse Transcriptase enzyme, and then degraded by RNAse H treatment. The second-strand cDNA was synthesized using DNA Polymerase I and dNTP. The remaining overhangs were converted into blunt ends via treatment with exonuclease/polymerase after the addition of 3' ends of DNA fragments. The adaptors ligated the preparation of the hybridization step with hairpin loop structures. cDNA fragments with a preferred length of 370–420 bp were selected, and the library fragments were purified by the AMPure XP system (Beckman Coulter Inc., Brea, CA, USA). PCR assays were performed with Phusion High-Fidelity DNA polymerase, Universal PCR primers and Index (X) Primer. Finally, the PCR products were purified (AMPure XP System; Beckman Coulter Inc.), and the library quality was assessed on the Qubit2.0 fluorometer (Agilent Bioanalyzer 2100 System; Agilent Technologies Inc.) and by qRT-PCR.
Data analysis
In-house Perl scripts were first used to obtain raw data (raw reads) in the FASTq format. In this step, clean data could be obtained (clean reads) by removing reads containing adapters, N base and low-quality reads from the raw data. Simultaneously, Q20, Q30, GC content and clear data were calculated. All downstream analyses were based on clean data of high quality [25].
Hierarchical clustering
The co-expression patterns of genes at different time points after infection were determined by cluster analysis of differentially expressed genes (DEGs). Genes with similar expression patterns were grouped into clusters. K-means clustering was achieved based on the relative expression level of DEGs log2 (fold change [FC]) [26].
Samples used for RNA sequencing were validated, and Pearson correlation analysis was used to assess the correlation of gene expression levels between samples. The square of Pearson correlation coefficient (R2) < 0.92 was defined as the optimal sampling selection and experimental condition [27].
The DESeq2R software package (version 1.20.0) was used to analyze differential expression between the two groups (experimental and control). The Benjamini–Hochberg method was used to adjust the P-value to regulate the error detection rate. The genes with adjusted P < 0.05 found by the DESeq2 software were designated as different genes [28, 29].
Gene ontology enrichment and Kyoto Encyclopedia of Genes and Genomes analysis
We used GOseq and KOBAS software for gene ontology (GO) functional enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) annotation and pathway enrichment analysis of differential gene sets. Regulation of false discovery rate < 0.05 and P < 0.05 were considered to be a significant enrichment pathway.
qRT-PCR validation of data
A sample of total RNA of approximately 1 ug was taken for further study based on the measured concentration. A capacity RNA kit was then used to synthesize cDNA by reverse transcription (Vazyme, Nanjing, China). qRT-PCR gene primers were designed using Premier 5.0 software. The components were mixed in advance using SYBR qPCR Master Mix (Vazymea), and the samples were then placed in a Roche LifeCycler® 96 real-time system for PCR cycling, with the cycling regimen consisting of 1 cycle at 95 °C for 30 s, followed by 40 cycles at 95 °C for 10 s and 60 °C for 30 s. Three independent replicates were used for each sample. β-Actin was used as an internal standard for gene expression normalization. The blank control group was taken as the reference sample and set as 1. Additional relative quantification of the target mRNA was performed using the cycle threshold (Ct) 2−∆∆Ct method. The genes and primers used in qRT-PCR are shown in Table 1.
Table 1.
Gene names and primers used in the quantitative reverse-transcription PCR analysis
| Genea | Sequence (5′-3′) | Primer length (mer) |
|---|---|---|
| CCL5 | F: CCAGCAGTCGTCTTTGTCAC | 20 |
| R: CTCTGGGTTGGCACACACTT | 20 | |
| CCL8 | F: TGGAGAGCTACACAAGAATCACC | 23 |
| R: TGGTCCAGATGCTTCATGGAA | 21 | |
| CCL23 | F: CATCTCCTACACCCCACGAAG | 22 |
| R: GGGTTGGCACAGAAACGTC | 21 | |
| CASP8 | F: TTTCTGCCTACAGGGTCATGC | 21 |
| R: TGTCCAACTTTCCTTCTCCCA | 21 | |
| TLR1 | F: TTCAAACGTGAAGCTACAGGG | 21 |
| R: CCGAACACATCGCTGACAACT | 21 | |
| TLR4 | F: AGACCTGTCCCTGAACCCTAT | 21 |
| R: CGATGGACTTCTAAACCAGCCA | 22 | |
| STAT1 | F: CAGCTTGACTCAAAATTCCTGGA | 23 |
| R: TGAAGATTACGCTTGCTTTTCCT | 23 | |
| ROS1 | F: GGCTGCCTATGGATTTCTGTG | 21 |
| R: GCTGCTGGCCCAGATTAGTT | 20 | |
| NOS1 | F: TTCCCTCTCGCCAAAGAGTTT | 21 |
| R: AAGTGCTAGTGGTGTCGATCT | 21 | |
| NOS2 | F: TTCAGTATCACAACCTCAGCAAG | 23 |
| R: TGGACCTGCAAGTTAAAATCCC | 22 |
F Forward, R reverse
aSee Table 2 for a full description
Results
Confirmation of T. gondii infection
A 194-bp fragment of the B1 gene and a 200-bp fragment of the BAG1 gene were successfully amplified by PCR and qRT-PCR, respectively. The presence of these fragments was additional confirmation of the existence of T. gondii cysts in brain tissue.
RNA-sequencing data
The RNA templates of the RNA libraries in both the infection group and control group were all > 8.0. The high-quality of the RNA libraries facilitated the analysis of subsequent data.
According to the quality evaluation results obtained, 130,016,821 clean reads remained after removing joints and low-quality reads. A total of 2808 DEGs were detected and screened in the brain tissue taken from the masked palm civets, of these 860 were upregulated DEGs and 1948 were downregulated DEGs. Compared with the reference genome, this could reach 82.5%. The GC content of the three samples from animals in the experimental group was remarkably different from that of the three animals in the control group, indicating the quality of RNA sequencing. A quality score of 20 and 30 (Q20 and Q30, respectively) indicates that the detection accuracy of the inferred basis was 97.81% and 94.19%, respectively. The results of detailed sequencing are shown in Table 2.
Table 2.
Results from the RNA-sequencing clean data analysis
| Source of sample | Sample | Raw reads | Clean reads | Clean bases | Error (%) | Q20 (%)a | Q30 (%)a | GC content (%) |
|---|---|---|---|---|---|---|---|---|
| Infected animal | M_1 | 23,038,190 | 21,613,812 | 6.48G | 0.03 | 97.79 | 94.17 | 52.91 |
| M_2 | 23,687,149 | 22,424,278 | 6.73G | 0.03 | 97.86 | 94.2 | 52.16 | |
| M_3 | 22,740,572 | 21,415,289 | 6.42G | 0.03 | 97.82 | 94.21 | 52.87 | |
| Control animal | cM_1 | 23,501,179 | 22,220,310 | 6.67G | 0.03 | 97.73 | 93.98 | 52.6 |
| cM_2 | 21,444,553 | 20,346,356 | 6.10G | 0.03 | 97.73 | 94.04 | 53.5 | |
| cM_3 | 23,479,997 | 21,996,776 | 6.60G | 0.02 | 97.93 | 94.53 | 52.93 |
aQ20, quality score of 20, representing an error rate of 1 in 100; Q30 indicates that all of the reads will be perfect, with no errors or ambiguities
The Pearson correlation coefficient of gene expression at different time points was close to 1, indicating a high similarity of gene expression patterns among samples (Fig. 1).
Fig. 1.

Heat map showing the size of the Pearson correlation coefficient (R2) matrix between different groups. The abscissa is the log10 (FPKM + 1) of sample 1, and the ordinate is the log10 (FPKM + 1) of sample 2. FPKM, Fragments per kilobase of exon per million mapped fragments
A total of 2808 up- or downregulated DEGs of T. gondii-infected masked civets were transformed into differential genes of BALB/c mice, and a total of 651 differential genes were obtained (Additional file 1: Table S1) and compared with data from BALB/c mice T. gondii-infected (PRJNA702090) (Additional file 2: Table S2). Through the comparison, a total of 304 DEGs with the same expression patterns (Additional file 3: Table S3) were identified. The KEGG pathway analysis shows the most commonly upregulated (Fig. 2a) and downregulated DEGs (Fig. 2b) in the enrichment pathways. These results indicated that some of the differential genes of T. gondii-infected masked civet also had the same expression pattern in T. gondii BALB/c mice.
Fig. 2.
KEGG pathway analysis bar graph of the top 15 differentially expressed genes (DEGs) in terms of enrichment degree. The X-axis shows gene amount, and the Y-axis corresponds to the KEGG pathway. A Upregulated gene enrichment pathway, B downregulated gene enrichment pathway. KEGG Kyoto Encyclopedia of Genes and Genomes
Transcriptome data are represented in Fig. 3a as a cluster map and in Fig. 3b as a volcano map. The results showed an obvious difference between the infected animals and the control animals, and the difference between biological repeats DEGs was small (P-value < 0.05; log2 FC > 1.5). Ten differentially expressed genes and their expression levels were verified by qRT-PCR, and the results of qRT-PCR were consistent with those of RNA-sequencing (RNA-Seq), which proved the authenticity and genuine validity of the sequencing data (Fig. 4).
Fig. 3.
RNA sequencing and transcript differential expression analysis. A Clustering gene heat map. The ordinate is the clustering result of DEGs; the abscissa represents the trial number. B Volcano map of DEGs. Red represents upregulated DEGs, and green represents downregulated DEGs
Fig. 4.
qRT-PCR verifies the results of RNA-sequencing. The X-axis represents the gene’s name, and the Y-axis represents the relative expression of the gene. DEGs above the horizontal line are upregulated and those below the horizontal line are downregulated. qRT-PCR Quantitative reverse-transciption PCR
GO and KEGG enrichment analysis
GO functional enrichment and KEGG pathway analysis were performed on transcription data on DEGs from samples from infected animals and control animals.
The GO functional annotations analysis explores the biological functions of DEGs. GO annotations include bBiological processes (BP), cellular components (CC) and molecular function (MF). All DEGs were detected in the brain tissues of chronically infected masked civet. A statistical column chart was drawn to reflect the analysis results of the enriched GO term (Fig. 5). The cell treatment process, metabolic process, cell differentiation and biological regulation were the major vital processes in terms of biological functions.
Fig. 5.
The GO analysis of the DETs. The GO is distributed into three main categories: biological process, cellular component and molecular function. The X-axis represents the GO term corresponding to the gene, and the Y-axis represents the number of genes. GO Gene ontology
The results of the KEGG functional annotation analysis of DEGs is shown in Fig. 6. The KEGG database was utilized to analyze pathway enrichment. DEGs of each group were further explored in those pathways that play an essential role in chronic infection of T. gondii and then plotted to scatter maps. In total, 168 pathways were found to be enriched with upregulated DEGs. The pathway maps of the top 20 gene enrichment levels was screened. (Fig. 7a). These include neuroactive ligand-receptor interaction, proteoglycans in cancer, transcriptional downregulation in cancer and melanogenesis. Among the downregulated DEGs, 194 pathways were enriched, and the top 20 pathways with the highest enrichment were screened out (Fig. 7b). These include dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), protein digestion and absorption and transcriptional downregulation in cancer. Lastly, all KEGG pathways of all DEGs were analyzed. The top 20 pathways were screened out (Fig. 7c), including, transcriptional downregulation in cancer, neuroactive ligand-receptor interaction, protein digestion and absorption, viral myocarditis, among others.
Fig. 6.
Pathway analysis of DEGs in KEGG. Differential gene function enrichment pathways mainly involve signal transduction, the immune system, the endocrine system and transport and catabolism
Fig. 7.
Scatter map of the top 20 enriched pathways in the KEGG pathway analysis. The X-axis shows enrichment factors, and the Y-axis corresponds to the KEGG pathway. A Upregulated gene enrichment pathways, B downregulated gene enrichment pathways, C pathway enrichment analysis of overall genes
The GO and KEGG analysis revealed that DEGs were abundant in the immune pathway. The chemokine signaling pathway, Toll-like receptor (TLR) signaling pathway, JAK-STAT signaling pathway, T cell receptor signaling pathway and PI3K-Akt signaling pathways were all enriched. In terms of the immune system, 10 essential driver genes were screened: CCL5, CCL8, CCL23, CASP8, TLR1, TLR4, STAT1, ROS1, NOS1 and NOS2 (Table 3).
Table 3.
Partial list of differentially expressed genes in Toxoplasma gondii-infected masked civet brain
| Gene symbol | Full name of gene | Log2 (FC) | Differential expression |
|---|---|---|---|
| CCL8 | C–C motif chemokine ligand 8 | 6.5608 | Upregulated |
| CCL23 | C–C motif chemokine ligand 23 | 6.17868 | Upregulated |
| TLR1 | Toll-like receptor 1 | 5.61362 | Upregulated |
| TLR4 | Toll-like receptor 4 | 1.53097 | Upregulated |
| CCL5 | C–C motif chemokine ligand 5 | 1.29567 | Upregulated |
| CASP8 | Caspase 8 | 1.11099 | Upregulated |
| NOS2 | Nitric oxide synthase 2 | − 5.60721 | Downregulated |
| STAT1 | Signal transducer and activator of transcription 1 | − 3.40022 | Downregulated |
| ROS1 | ROS proto-oncogene 1 | − 3.41519 | Downregulated |
| NOS1 | Nitric oxide synthase 1 | − 1.60721 | Downregulated |
FC Fold change
Discussion
According to previous reports, T. gondii changes the behavior of its intermediate host due to the invasion of parasite cysts into the brain tissue. In one study, infected rodents were found to have decreased learning and memory, but increased activity [30]. In humans, T. gondii infection can also cause neurodegenerative diseases, such as mental disorders, schizophrenia and depression [31].
In this study, RNA-Seq analysis was performed on brain tissues extracted from masked civets chronically infected with T. gondii. Comparison of the results from the infected and control groups revealed 2808 DEGs, of which 860 were upregulated and 1948 were downregulated. We analyzed the pathway enrichment of all transcripts based on the GO and KEGG databases with the aim to evaluate the biological correlation of selected genes. Screening of the DEGs was related to the immune system. The chemokine signaling pathway, the TLR signaling pathway, T cell receptor signaling pathway, NOD-like receptor signaling pathway and JAK-STAT signaling pathway are actual examples of immune pathways with high gene enrichment.
Toxoplasma gondii infection is thought to damage the brain tissue and is a risk factor for neurological and mental disorders. Recently, the chemokine system involved in the immune response has been considered a vital element of signal transduction and neural function in brain cells [32]. Previous analyses of the KEGG pathway revealed that chronic infection of T. gondii can cause enhanced chemokine signaling [33, 34], and occasionally release chemokines through inflammatory cytokines such as interleukin-1 (IL-1) stimulation [35], Chemokines play a role by binding to different types of chemokine receptors on the surface of cell membranes, thereby helping to inhibit T. gondii infection. CCL5, CCL8 and CCL23 belong to the CC chemokine subfamily, and CCL5, CCL10, and CCL23 are also critical chemokines that attract mononuclear macrophages into inflammatory sites [36, 37].
Interferon gamma (IFN-γ) is an important cytokine that protects host cells from T. gondii invasion. Indoleamine-2 indoleamine 2,3-dioxygenase can be induced to convert tryptophan into l-formyluridine, which is necessary for the development and proliferation of T. gondii. Thus, the growth and expansion of T. gondii are inhibited by tryptophan starvation during the primary metabolism [38, 39]. Some studies have shown that STAT1 transcription factors mediate the IFN-γ response, which is essential for host defense against intracellular pathogens such as T. gondii. However, a previous infection with T. gondii can inhibit this response [40]. Previous studies have shown that mice without the IFN-γ receptor or the signal transducer and activator of the STAT1 gene are highly susceptible to T. gondii after inoculation with non-lethal T. gondii strains [41]. Furthermore, the inhibitor of STAT1 transcription (IST) plays a key role in limiting IFN-γ signaling in bradyzoites. The export of bradyzoite protein protects host cells from IFN-γ-mediated cell death, even when the export is restricted to latent stages [42]. In the present study, the genes encoding STAT1, NOS1, NOS2 and ROS1, all related to immunity, were simultaneously screened. Inhibition of STAT1 transcriptional activity can downregulate the expression of major histocompatibility complex and inducible nitric oxide synthase (iNOS), which is helpful for the survival of T. gondii. IFN-γ-induced iNOS and activated oxygen (reactive oxygen species) effector molecules can effectively resist the T. gondii invasion [43, 44]. PI3K-Akt signal transduction plays a vital role in T. gondii invasion of host cells because phosphatidylinositol (PIP3) accumulates rapidly in host cells in response to the infective tachyzoites. More importantly, PI3K inhibitors partially reduce parasite entry [45]. Akt can regulate various cell processes; for example, it can increase metabolism, control growth and synthesis and inhibit apoptosis. Therefore, we can infer that the PI3K-Akt signal pathway has an inhibitory effect on T. gondii invasion of masked civet and other wild species.
TLR signaling pathways can participate in non-specific immunity. Activation of the signal transduction pathway (Fig. 8), triggering the body to generate immune cell response and inducing the expression of inflammatory factors are important and effective mechanisms against T. gondii invasion of host cells [46, 47]. Previous studies have shown that the TLR signaling pathway plays a vital role in host resistance to T. gondii and its pathogenesis infection (Fig. 8). TLR1 and TLR4 may be expressed in T cells, mononuclear macrophages and lymphocytes and NK cells during T. gondii invasion. Toxoplasma gondii can also activate TLR4 to induce inflammation and mediate neuronal apoptosis, which plays a vital role in the inflammatory response induced by brain injury [48, 49]. We also screened the CASP8 gene for inflammatory body-mediated cell death, which is an essential pathway in controlling T. gondii host cell death [50]. It has been reported that CASP8 plays an indispensable role in regulating inflammation and can also act as an antigen to activate NF-kB and promote cytokine production [51].
Fig. 8.
TLR1- and TLR4-mediated activation of the body generates cellular immune responses through activation of the NF-κB signaling pathway, which can defend against the T. gondii invasion of the host. TRL, Toll-like receptor
Conclusion
In the present study, brain tissue samples were collected from masked palm civet chronically infected with T. gondii for transcriptome analysis, functional annotation and collateral analysis of differential genes. The immune pathways of highly enriched differential genes were screened; these mainly involved the chemokine signaling pathway, TLR signaling pathway, JAK-STAT signaling pathway, T cell receptor signaling pathway and PI3K-Akt signaling pathway. The immune pathway reported in this study may provide insights into the mechanism of the immune response to T. gondii chronic infection in wild species. The screened genes can be used as target genes to develop drugs to treat T. gondii-infected wild animals and, subsequently, implement effective prophylactic measures.
Supplementary Information
Additional file 1: Table S1. Masked civet differential genes transformation in BALB/c mice differential gene.
Additional file 2: Table S2. T. gondii-infected BALB/c mice differential genes
Additional file 3: Table S3. Masked civet and BALB/c mice co-expressed differential genes
Acknowledgements
We thank John Adams, Higher Colleges of Technology, UAE, for his great effort and time in proofreading this research work.
Abbreviations
- CASP8
Caspase-8
- CCL
C-C motif chemokine ligand
- DEGs
Differentially expressed genes
- GO
Gene ontology
- KEGG
Kyoto Encyclopedia of Genes and Genomes
- IFN-γ
Interferon gamma
- iNOS
Inducible nitric oxide synthase
- qRT-PCR
Quantitative reverse-transcription PCR
- ROS
Reactive oxygen species
- STAT
Signal transducer and activator of transcription
- TLR
Toll-like receptor
Author contributions
HY, XXZ, QYG and ZGY conceived and designed the study, and critically revised the manuscript. HY, ZPY, PZ and ZJY performed the experiment, analyzed the transcriptomic data and drafted the manuscript. YYW, ZWR, XHW, ZPY and YSM helped in data analysis and manuscript revision. All authors read and approved the final manuscript.
Funding
Funding for the present study was provided by The National Natural Science Foundation of China (31972707), the Scientific and Technological Research Projects of Foshan (2020001000151), the Key Research and Development Programme of Guangdong Province (2019B020218004) and the Natural Science Foundation of Guangdong Province (2019A1515011534).
Availability of data and materials
The sequencing data generated in this study have been deposited into BioProject (accession no. PRJNA760987, https://www.ncbi.nlm.nih.gov/bioprjet/PRJNA760987).
Declarations
Ethics approval and consent to participate
The Animal Administration Committee of South China Agricultural University approved all animal experiments (No. SCAU2021f163).
Consent for publication
Not applicable.
Competing interests
The authors declare no conflict of interest.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Hao Yuan, Xiu-Xiang Zhang and Zi-Peng Yang contributed equally to this work
Contributor Information
Qing-Yong Guo, Email: wlmqgqy@126.com.
Zi-Guo Yuan, Email: ziguoyuan@scau.edu.cn.
References
- 1.Liu Q, Wang ZD, Huang SY. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors. 2015;8:292–306. doi: 10.1186/s13071-015-0902-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Shiojiri D, Kinai E, Teruya K, Kikuchi Y. Combination of clindamycin and azithromycin as alternative treatment for Toxoplasma gondii encephalitis. Emerg Infect Dis. 2019;25:841–843. doi: 10.3201/eid2504.181689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis. 2012;44:805–814. doi: 10.3109/00365548.2012.693197. [DOI] [PubMed] [Google Scholar]
- 4.Valadkhani S, Radmard AR, Saeedi M, Nikpour S, Farnia MR. Toxoplasma encephalitis and AIDS in a patient with seizure and altered mental status: a case report. World J Emerg Med. 2017;8:65–67. doi: 10.5847/wjem.j.1920-8642.2017.01.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Perez JL, Gersey ZC, Marker DF, Zenonos GA, Zinn PO. Toxoplasma encephalitis presenting as neoplastic disease: a single-institution case series. Interdiscip Neurosurg. 2021;25:101–174. [Google Scholar]
- 6.Sgroi G, Viscardi M, Santoro MM, Borriello G. Genotyping of Toxoplasma gondii in wild boar (Sus scrofa) in southern Italy: Epidemiological survey and associated risk for consumers. Zoonoses Public Health. 2020;67:805–813. doi: 10.1111/zph.12762. [DOI] [PubMed] [Google Scholar]
- 7.Harun M, Marsh V, Elsaied NA, Webb KF, Elsheikha HM. Effects of Toxoplasma gondii infection on the function and integrity of human cerebrovascular endothelial cells and the influence of Verapamil treatment in vitro. Brain Res. 2020;1746:147002–147041. doi: 10.1016/j.brainres.2020.147002. [DOI] [PubMed] [Google Scholar]
- 8.Samojowicz D, Twarowska J, Borowska A, Poniatowski UA, Olczak M. Presence of Toxoplasma gondii infection in brain as a potential cause of risky behavior: a report of 102 autopsy cases. Eur J Clin Microbiol Infect Dis. 2019;38:12–13. doi: 10.1007/s10096-018-3427-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mayor AM, Santos DF, Dworkin MS, Rios-Olivares E, Hunter RF. Toxoplasmic encephalitis in an AIDS cohort at Puerto Rico before and after highly active antiretroviral therapy (HAART) Am J Trop Med. 2011;84:838–841. doi: 10.4269/ajtmh.2011.10-0718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sayed NM, Ismail KA, Ahmed A, Azzam E. Possible association between Toxoplasma gondii infection and schizophrenia. Infect Dis Clin Pract. 2012;20:394–399. [Google Scholar]
- 11.Ma Z, Mutashar AM, Kaminga AC, Lu B, Li X, Zhang J, et al. Bioinformatics of excretory/secretory proteins of Toxoplasma gondii strain ME49. Microb Pathog. 2020;140:103951. [DOI] [PubMed]
- 12.Hou GY, Zhao JM, Zhou HL, Rong G. Seroprevalence and genetic characterization of Toxoplasma gondii in masked palm civet (Paguma larvata) in Hainan province, tropical China. Acta Trop. 2016;162:103–106. doi: 10.1016/j.actatropica.2016.06.011. [DOI] [PubMed] [Google Scholar]
- 13.Lee K, Iwata T, Nakadai A, Kato T, Hayashidani H. Prevalence of Salmonella, Yersinia, and Campylobacter spp. in Feral Raccoons (Procyon lotor) and Masked Palm Civets (Paguma larvata) in Japan. Zoonoses Public Health. 2011;58:424–431. doi: 10.1111/j.1863-2378.2010.01384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Jaffe DA, Chomel BB, Kasten RW, Breitschwerdt EB, Zieger U. Bartonella henselae in small Indian mongooses (Herpestes auropunctatus) from Grenada, West Indies. Vet Microbiol. 2018;216:119–122. doi: 10.1016/j.vetmic.2018.02.009. [DOI] [PubMed] [Google Scholar]
- 15.Wicker LV, Canfield PJ, Higgins D. Potential pathogens reported in species of the family viverridae and their implications for human and animal health. Zoonoses Public Health. 2017;64:75–93. doi: 10.1111/zph.12290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Yu ZJ, Wen X, Huang X, Yang R, Guo YQ, Feng YY, et al. Molecular characterization and zoonotic potential of Enterocytozoon bieneusi, Giardia duodenalis, and Cryptosporidium sp. in farmed masked palm civets (Paguma larvata) in southern China. Parasit Vectors. 2020;13:1–10. doi: 10.1186/s13071-020-04274-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hatam K, Calero R, Rahimi MT, Pagheh AS, Ahmadpour E. Toxoplasma gondii infection in domestic and wild felids as public health concerns: a systematic review and meta-analysis. Sci Rep. 2021;11:9509–9520. doi: 10.1038/s41598-021-89031-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Jia B, Lu H, Quan L, Yin J, Ning J, Chen Q. Genome-wide comparative analysis revealed significant transcriptome changes in mice after Toxoplasma gondii infection. Parasit Vectors. 2013;6:1–12. doi: 10.1186/1756-3305-6-161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Pittman KJ, Aliota MT, Knoll L. Dual transcriptional profiling of mice and Toxoplasma gondii during acute and chronic infection. BMC Genomics. 2014;15:806–825. doi: 10.1186/1471-2164-15-806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Cong W, Tania D, Faraz K, Richard E. Acute Toxoplasma gondii Infection in cats induced tissue-specific transcriptional response dominated by immune signatures. Front Immunol. 2018;9:2403–2417. doi: 10.3389/fimmu.2018.02403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wohlfert EA, Blader IJ, Wilson EH. Brains and brawn: toxoplasma infections of the central nervous system and skeletal muscle. Trends Parasitol. 2017;33:519–531. doi: 10.1016/j.pt.2017.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Reperant LA, Hegglin D, Tanner I, Fischer C, Deplazes P. Rodents as shared indicators for zoonotic parasites of carnivores in urban environments. Parasitology. 2009;136:329–337. doi: 10.1017/S0031182008005428. [DOI] [PubMed] [Google Scholar]
- 23.Burg JL, Grover CM, Pouletty P, Boothroyd JCJ. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol. 1989;27:1787–1792. doi: 10.1128/jcm.27.8.1787-1792.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ye YB, Liang LD, Hua YJ, Zhao Z, Liang CZ. High-purity. DNA extraction from animal tissue using picking in the TRIzol-based method. Biotechniques. 2020;70:36–45. doi: 10.2144/btn-2020-0142. [DOI] [PubMed] [Google Scholar]
- 25.Juliana CS, Douglas D, Martins LF. RNA-Seq differential expression analysis: an extended review and a software tool. PLoS ONE. 2017;12:e0190152. doi: 10.1371/journal.pone.0190152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Hosseini P, Tremblay A, Matthews BF, Alkharouf NW. An efficient annotation and gene-expression derivation tool for Illumina Solexa datasets. BMC Res Notes. 2010;3:1–7. doi: 10.1186/1756-0500-3-183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Grabherr MG, Haas BJ, Yassour M, Levin JZ, Thompson DA, Amit I, et al. Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat Biotechnol. 2011;29:644–652. doi: 10.1038/nbt.1883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Bens M, Sahm A, Groth M, Jahn N, Morhart M, Holtze S, et al. FRAMA: from RNA-seq data to annotated mRNA assemblies. BMC Genomics. 2016;17:54–66. doi: 10.1186/s12864-015-2349-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Vieth B, Parekh S, Ziegenhain C, Enard W, Hellmann I. A systematic evaluation of single cell RNA-seq analysis pipelines. Nat Commun. 2019;10:1–11. doi: 10.1038/s41467-019-12266-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Webster JP. The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophr Bull. 2007;3:752–756. doi: 10.1093/schbul/sbl073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Dalimi A, Abdoli A. Latent toxoplasmosis and human. Iran J Parasitol. 2012;7:1–17. [PMC free article] [PubMed] [Google Scholar]
- 32.Kobayashi K, Umeda K, Ihara F, Tanaka S, Yamagishi J, Suzuki Y, et al. Transcriptome analysis of the effect of C-C chemokine receptor 5 deficiency on cell response to Toxoplasma gondii in brain cells. BMC Genomics. 2019;20:705–719. doi: 10.1186/s12864-019-6076-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Nejad MR, Sherafat SJ, Roshani M, Telkabadi M, Alavi-Moghaddam M. The evaluation of interleukin-8 chemokine in chronic and acute Toxoplasma gondii infection. Gastroenterology. 2011;4:34–37. [PMC free article] [PubMed] [Google Scholar]
- 34.Menzies FM, Macphail David H, Fiona L. The role of chemokines and their receptors during protist parasite infections. Parasitology. 2016;143:1890–1901. doi: 10.1017/S0031182016001694. [DOI] [PubMed] [Google Scholar]
- 35.Raghu H, Lepus CM, Wang Q, Wong HH, Lingampalli N, Oliviero F, et al. CCL2/CCR2 but not CCL5/CCR5 mediates monocyte recruitment inflammation and cartilage destruction in osteoarthritis. Ann Rheum Dis. 2017;76:914–922. doi: 10.1136/annrheumdis-2016-210426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ge B, Li J, Wei Z, Sun T, Song Y, Khan NU. Functional expression of CCL8 and its interaction with chemokine receptor CCR3. BMC Immunol. 2017;18:54–62. doi: 10.1186/s12865-017-0237-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Sabia C, Montesano M, Napoli C. Transplantation and host immune response to Toxoplasma gondii. Transpl Infect Dis. 2013;15:124–125. doi: 10.1111/tid.12076. [DOI] [PubMed] [Google Scholar]
- 38.Li Y, Yuan L, Xiu F, Wang J, Hua C, He S, et al. Characterization of exosomes derived from Toxoplasma gondii and their functions in modulating immune responses. Nanomedicine. 2018;13:467–477. doi: 10.2147/IJN.S151110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Rosowski EE, Nguyen QP, Camejo A, Spooner E, Saeij J, Adams J. Toxoplasma gondii inhibits gamma interferon (IFN-γ)- and IFN-β-induced host cell STAT1 transcriptional activity by increasing the association of STAT1 with DNA. Infect Immun. 2014;82:706–719. doi: 10.1128/IAI.01291-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Gabrielle G, Laurence B, Marie P, Brenier P, Julien VV. Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-γ-mediated host defenses. J Exp Med. 2016;213:1779–1798. doi: 10.1084/jem.20160340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Andrade MC, Galvo CVL, AA, Fonseca TR, Figueiredo CA. Toxoplasma gondii protects from IgE sensitization and induces Th1/Th2 immune profile. Parasite Immunol. 2020;42:e12694. doi: 10.1111/pim.12694. [DOI] [PubMed] [Google Scholar]
- 42.Seizova S, Ruparel U, Garnham AL, Bader SM, Uboldi AD, Coffey MJ, et al. Transcriptional modification of host cells harboring Toxoplasma gondii bradyzoites prevents IFN gamma-mediated cell death. Cell Host Microbe. 2022;30:232–247. doi: 10.1016/j.chom.2021.11.012. [DOI] [PubMed] [Google Scholar]
- 43.Kang HI, Chu K, Lee S, Kim MU. Toxoplasma gondii virus-like particle vaccination alleviates inflammatory response in the brain upon T. gondii infection. Parasite Immunol. 2020;42:e12716. doi: 10.1111/pim.12716. [DOI] [PubMed] [Google Scholar]
- 44.Manea A, Tanase LI, Raicu M, Simionescu M. Transcriptional regulation of NADPH oxidase isoforms Nox1 and Nox4 by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem Biophys Res Commun. 2010;396:901–907. doi: 10.1016/j.bbrc.2010.05.019. [DOI] [PubMed] [Google Scholar]
- 45.Parker SJ, Roberts CW, Alexander J. CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin Exp Immunol. 2008;84:207–212. doi: 10.1111/j.1365-2249.1991.tb08150.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Denkers EY. Toll-like receptor initiated host defense against Toxoplasma gondii. J Biomed Biotechnol. 2010;2010:737125–737132. doi: 10.1155/2010/737125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Li M, Wang H, Li W, Xu XG, Yu Y. Macrophage activation on "phagocytic synapse" arrays: Spacing of nanoclustered ligands directs TLR1/2 signaling with an intrinsic limit. Sci Adv. 2020;6:e8482. doi: 10.1126/sciadv.abc8482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Melanie F, Günther S, Robin S, Marie-Christine A, Fabian S, Paul WJ, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis, and pyroptosis. Nature. 2019;575:683–687. doi: 10.1038/s41586-019-1770-6. [DOI] [PubMed] [Google Scholar]
- 49.Yarovinsky F, Sher A. Toll-like receptor recognition of Toxoplasma gondii. Int J Parasitol. 2006;36:255–259. doi: 10.1016/j.ijpara.2005.12.003. [DOI] [PubMed] [Google Scholar]
- 50.Yarovinsky F. Toll-like receptors and their role in host resistance to Toxoplasma gondii. Immunol Lett. 2008;119:17–21. doi: 10.1016/j.imlet.2008.05.007. [DOI] [PubMed] [Google Scholar]
- 51.Shokri M, Tappeh KH, Meshkini E, Aminpour A. Evaluation of toll-like receptor 11 agonist adjuvant activity in immunization of BALB/c Mice with total lysate antigens of Toxoplasma gondii RH strain. Iran J Parasitol. 2020;15:349–356. doi: 10.18502/ijpa.v15i3.4199. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Additional file 1: Table S1. Masked civet differential genes transformation in BALB/c mice differential gene.
Additional file 2: Table S2. T. gondii-infected BALB/c mice differential genes
Additional file 3: Table S3. Masked civet and BALB/c mice co-expressed differential genes
Data Availability Statement
The sequencing data generated in this study have been deposited into BioProject (accession no. PRJNA760987, https://www.ncbi.nlm.nih.gov/bioprjet/PRJNA760987).








